custom image

Joint meeting with Plant Genome Engineering: From Lab to Field

Precision Engineering of the Genome, Epigenome and Transcriptome

March 8-10, 2021 | 10:00AM EST | 3:00PM UTC | 4:00PM CET*
*Program is in development and subject to change



Joint Meetings

Your registration provides you with access to both the “Precision Engineering of the Genome, Epigenome and Transcriptome” and “Plant Genome Engineering: From Lab to Field” eSymposia events. Use the link below to explore the joint meeting features, including live plenary sessions, On Demand talks, posters, forums, job postings, 1:1 Connect appointments and more. This joint meeting access is designed to facilitate cross-disciplinary insights and collaborations to drive both fields in exciting new directions!

  View Joint Meeting On Demand



Reset

Advanced Filters
10:00am - 10:40am EDT - March 8, 2021
Fyodor D. Urnov, PhD, Chair, University of California, Berkeley; Tim W. Yu, MD, PhD, Keynote, Boston Children's Hospital
Track: Welcome and Keynote Address

Monday
10:00am - 10:40am EDT - March 8, 2021
Tim W. Yu, MD, PhD, Boston Children's Hospital
Track: Welcome and Keynote Address

10:40am - 01:00pm EDT - March 8, 2021
Samuel H. Sternberg, PhD, Co-Chair, Columbia University; Patrick D. Hsu, PhD, Co-Chair, University of California, Berkeley
Track: Engineering of Editors and Epi-Editors

Monday
10:40am - 11:05am EDT - March 8, 2021
Samuel H. Sternberg, PhD, Columbia University
Track: Engineering of Editors and Epi-Editors

Monday
11:05am - 11:30am EDT - March 8, 2021
Cecilia Cotta-Ramusino, PhD, Tessera Therapeutics
Track: Engineering of Editors and Epi-Editors

Monday
11:40am - 12:05pm EDT - March 8, 2021
Patrick D. Hsu, PhD, University of California, Berkeley
Track: Engineering of Editors and Epi-Editors

Monday
12:05pm - 12:30pm EDT - March 8, 2021
Prashant Mali, PhD, University of California, San Diego
Track: Engineering of Editors and Epi-Editors

Monday
12:30pm - 12:45pm EDT - March 8, 2021
Track: Engineering of Editors and Epi-Editors

Monday

Monday
02:30pm - 03:30pm EDT - March 8, 2021
Britt S. Adamson, PhD, Panelist, Princeton University; Rachel E. Haurwitz, PhD, Panelist, Caribou Biosciences, Inc.; Steven E. Jacobsen, PhD, Panelist, University of California, Los Angeles
Track: Career Roundtable

05:00pm - 08:00pm EDT - March 8, 2021
Charles Gersbach, PhD, Co-Chair, Duke University; Henriette O'Geen, PhD, Co-Chair, University of California, Davis
Track: Controlling CRISPR

Monday
05:00pm - 05:25pm EDT - March 8, 2021
Jacob E. Corn, PhD, ETH Zürich
Track: Controlling CRISPR

Monday
05:25pm - 05:50pm EDT - March 8, 2021
Bas van Steensel, PhD, Netherlands Cancer Institute
Track: Controlling CRISPR

Monday
05:50pm - 06:15pm EDT - March 8, 2021
Ahmad S. Khalil, PhD, Boston University
Track: Controlling CRISPR

Monday
06:35pm - 07:00pm EDT - March 8, 2021
Jennifer E. Phillips-Cremins, PhD, University of Pennsylvania
Track: Controlling CRISPR

Monday
07:00pm - 07:15pm EDT - March 8, 2021
Alyna Yamuna Katti, BS, Weill Cornell Medicine
Track: Controlling CRISPR

Monday
07:30pm - 07:45pm EDT - March 8, 2021
Henriette O'Geen, PhD, University of California, Davis
Track: Controlling CRISPR

10:00am - 01:00pm EDT - March 9, 2021
Rachel E. Haurwitz, PhD, Co-Chair, Caribou Biosciences, Inc.; Nicole Gaudelli, PhD, Co-Chair, Beam Therapeutics
Track: Therapeutics I: Ex Vivo Editing

Tuesday
10:00am - 10:25am EDT - March 9, 2021
Rachel E. Haurwitz, PhD, Caribou Biosciences, Inc.
Track: Therapeutics I: Ex Vivo Editing

Tuesday
10:25am - 10:50am EDT - March 9, 2021
Matthew Porteus, MD, PhD, Stanford University School of Medicine
Track: Therapeutics I: Ex Vivo Editing

Tuesday
10:50am - 11:15am EDT - March 9, 2021
Chiara Bonini, MD, Vita-Salute San Raffaele University
Track: Therapeutics I: Ex Vivo Editing

Tuesday
11:35am - 12:00pm EDT - March 9, 2021
Nicole Gaudelli, PhD, Beam Therapeutics
Track: Therapeutics I: Ex Vivo Editing

Tuesday
12:00pm - 12:15pm EDT - March 9, 2021
Delphine Guipouy, PhD, CHU Sainte Justine Research Center
Track: Therapeutics I: Ex Vivo Editing

Tuesday
12:15pm - 12:30pm EDT - March 9, 2021
Dimitrios Laurin Wagner, MD, Charité - Universitätsmedizin Berlin
Track: Therapeutics I: Ex Vivo Editing

Tuesday
12:30pm - 12:45pm EDT - March 9, 2021
Adrian Veres, PhD, Harvard University
Track: Therapeutics I: Ex Vivo Editing

Tuesday
12:45pm - 01:00pm EDT - March 9, 2021
Sébastien Levesque, MS, CHU de Québec - Université Laval
Track: Therapeutics I: Ex Vivo Editing

Tuesday
02:30pm - 03:30pm EDT - March 9, 2021
Holger Breithaupt, PhD, Panelist, EMBO Press; Kevin Davies, Panelist, The CRISPR Journal; Bing Yang, Panelist, Frontiers in Genome Editing; Ruth Zearfoss, PhD, Panelist, Cell Reports Methods, Cell Press; Roland Roberts, PhD, Panelist, PLOS (Public Library of Science); Caitlin Karniski, PhD, Panelist, Nature Portfolio
Track: Meet the Editors Roundtable

05:00pm - 07:45pm EDT - March 9, 2021
Fyodor D. Urnov, PhD, Co-Chair, University of California, Berkeley; Ana Moreno Collado, PhD, Co-Chair, Navega Therapeutics
Track: Therapeutics II: In Vivo Editing

Tuesday
05:00pm - 05:25pm EDT - March 9, 2021
David G. Ousterout, PhD, Locus Biosciences, Inc.
Track: Therapeutics II: In Vivo Editing

Tuesday
05:25pm - 05:50pm EDT - March 9, 2021
Fyodor D. Urnov, PhD, University of California, Berkeley
Track: Therapeutics II: In Vivo Editing

Tuesday
05:50pm - 06:15pm EDT - March 9, 2021
Aravind Asokan, PhD, Duke University
Track: Delivery

Tuesday
06:35pm - 07:00pm EDT - March 9, 2021
Ana Moreno Collado, PhD, Navega Therapeutics
Track: Therapeutics II: In Vivo Editing

Tuesday
07:00pm - 07:15pm EDT - March 9, 2021
Chikdu Shivalila, PhD, Wave Life Sciences
Track: Therapeutics II: In Vivo Editing

Tuesday
07:15pm - 07:30pm EDT - March 9, 2021
Jia Qi Cheng-Zhang, MS, University of Pittsburgh
Track: Therapeutics II: In Vivo Editing

Tuesday
07:30pm - 07:45pm EDT - March 9, 2021
Serena Tamura, BA, University of California San Francisco
Track: Therapeutics II: In Vivo Editing

10:00am - 12:50pm EDT - March 10, 2021
Charles Gersbach, PhD, Co-Chair, Duke University; Daniel J. Siegwart, PhD, Co-Chair, University of Texas Southwestern Medical Center
Track: Delivery

Wednesday
10:00am - 10:25am EDT - March 10, 2021
Daniel J. Siegwart, PhD, University of Texas Southwestern Medical Center
Track: Delivery

Wednesday
10:25am - 10:50am EDT - March 10, 2021
Charles Gersbach, PhD, Duke University
Track: Therapeutics II: In Vivo Editing

Wednesday
10:50am - 11:15am EDT - March 10, 2021
James Dahlman, PhD, Georgia Tech / Emory Medical School
Track: Delivery

Wednesday

Wednesday

Wednesday
12:20pm - 12:35pm EDT - March 10, 2021
Kiara Berrios, BS, University of Pennsylvania
Track: Delivery

05:00pm - 08:00pm EDT - March 10, 2021
John G. Doench, PhD, Co-Chair, Broad Institute of MIT and Harvard University; Britt S. Adamson, PhD, Co-Chair, Princeton University
Track: Screening & Single Cell Technologies

Wednesday
05:00pm - 05:25pm EDT - March 10, 2021
John G. Doench, PhD, Broad Institute of MIT and Harvard University
Track: Screening & Single Cell Technologies

Wednesday
05:25pm - 05:50pm EDT - March 10, 2021
Britt S. Adamson, PhD, Princeton University
Track: Screening & Single Cell Technologies

Wednesday
05:50pm - 06:15pm EDT - March 10, 2021
Hyongbum Henry Kim, MD, PhD, Yonsei University College of Medicine
Track: Screening & Single Cell Technologies

Wednesday
06:30pm - 06:55pm EDT - March 10, 2021
Jonathan S. Weissman, PhD, Whitehead Institute and MIT
Track: Screening & Single Cell Technologies

Wednesday
06:55pm - 07:10pm EDT - March 10, 2021
Alberto Ciccia, PhD, Columbia University
Track: Screening & Single Cell Technologies

Wednesday
07:10pm - 07:25pm EDT - March 10, 2021
Brian Cosgrove, PhD, Duke University
Track: Screening & Single Cell Technologies

Wednesday
07:25pm - 07:40pm EDT - March 10, 2021
Pratiksha Thakore, PhD, Broad Institute
Track: Screening & Single Cell Technologies

Wednesday
07:40pm - 07:55pm EDT - March 10, 2021
Sarah Elisabeth Pierce, BS, Stanford University
Track: Screening & Single Cell Technologies

Wednesday
07:55pm - 08:00pm EDT - March 10, 2021
Track: Screening & Single Cell Technologies